Immunosuppression by anti-cd4 treatment in vivo

M. Weyand Cornelia; Goronzy Jorg; Swarztrauber Kari; C. Garrison Fathman

doi:10.1097/00007890-198906000-00023

Immunosuppression by anti-cd4 treatment in vivo

M. Weyand Cornelia, Goronzy Jorg, Swarztrauber Kari, C. Garrison Fathman

Immunology

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

Elimination of CD4+ helper T cells by treatment with monoclonal antibodies (mcAb) in vivo has been used as a new mode of immunosuppression in organ transplantation and autoimmune diseases. To explore the potential risks of this therapeutic approach we have studied antiviral responses in mice depleted of CD4+ T cells.

Original language	English (US)
Pages (from-to)	1034-1038
Number of pages	5
Journal	Transplantation
Volume	47
Issue number	6
DOIs	https://doi.org/10.1097/00007890-198906000-00023
State	Published - Jun 1989

ASJC Scopus subject areas

Transplantation

Access to Document

10.1097/00007890-198906000-00023

Cite this

@article{a0c4053bd53b4906ad3f10ebc21719d8,

title = "Immunosuppression by anti-cd4 treatment in vivo",

abstract = "Elimination of CD4+ helper T cells by treatment with monoclonal antibodies (mcAb) in vivo has been used as a new mode of immunosuppression in organ transplantation and autoimmune diseases. To explore the potential risks of this therapeutic approach we have studied antiviral responses in mice depleted of CD4+ T cells.",

author = "Cornelia, {M. Weyand} and Goronzy Jorg and Swarztrauber Kari and Fathman, {C. Garrison}",

year = "1989",

month = jun,

doi = "10.1097/00007890-198906000-00023",

language = "English (US)",

volume = "47",

pages = "1034--1038",

journal = "Transplantation",

issn = "0041-1337",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Immunosuppression by anti-cd4 treatment in vivo

AU - Cornelia, M. Weyand

AU - Jorg, Goronzy

AU - Kari, Swarztrauber

AU - Fathman, C. Garrison

PY - 1989/6

Y1 - 1989/6

N2 - Elimination of CD4+ helper T cells by treatment with monoclonal antibodies (mcAb) in vivo has been used as a new mode of immunosuppression in organ transplantation and autoimmune diseases. To explore the potential risks of this therapeutic approach we have studied antiviral responses in mice depleted of CD4+ T cells.

AB - Elimination of CD4+ helper T cells by treatment with monoclonal antibodies (mcAb) in vivo has been used as a new mode of immunosuppression in organ transplantation and autoimmune diseases. To explore the potential risks of this therapeutic approach we have studied antiviral responses in mice depleted of CD4+ T cells.

UR - http://www.scopus.com/inward/record.url?scp=84945004291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945004291&partnerID=8YFLogxK

U2 - 10.1097/00007890-198906000-00023

DO - 10.1097/00007890-198906000-00023

M3 - Article

C2 - 2472023

AN - SCOPUS:84945004291

VL - 47

SP - 1034

EP - 1038

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 6

ER -

Immunosuppression by anti-cd4 treatment in vivo

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this